Market Tracker

10/20 5:16pm ET

OPKO Health Inc (NASDAQ:OPK)

6.96
Delayed Data
As of Oct 20
 +0.21 / +3.11%
Today’s Change
5.85
Today|||52-Week Range
12.15
-25.16%
Year-to-Date

Today’s Trading

Previous close6.75
Today’s open6.74
Day’s range6.72 - 6.99
Volume3,531,296
Average volume (3 months)4,515,738
Market cap$3.9B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-283.33%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.18+0.36%
CLVSClovis Oncology Inc+0.73+0.95%
PBYIPuma Biotechnology I...+3.05+2.51%
MNKMallinckrodt Plc-0.40-1.22%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts